We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

114 hedge funds and large institutions have $489M invested in MaxCyte in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

82% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 28

30% more capital invested

Capital invested by funds: $376M → $489M (+$113M)

10% more funds holding

Funds holding: 104 → 114 (+10)

3.27% less ownership

Funds ownership: 67.54% → 64.27% (-3.3%)

12% less call options, than puts

Call options by funds: $15K | Put options by funds: $17K

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
114
Holders Change
+10
Holders Change %
+9.62%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
16
Increased
51
Reduced
28
Closed
5
Calls
$15K
Puts
$17K
Net Calls
-$2K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$12M
2
Ameriprise
Ameriprise
Minnesota
+$6.55M
3
Millennium Management
Millennium Management
New York
+$4.67M
4
PCM
Portolan Capital Management
Massachusetts
+$3.06M
5
MA
Mudita Advisors
United Kingdom
+$2.82M

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$22.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$9.76M
3
PC
Pier Capital
Connecticut
-$5.86M
4
MAM
Montanaro Asset Management
United Kingdom
-$4.43M
5
Holocene Advisors
Holocene Advisors
New York
-$3.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
$35K +$20.4K +4,144 +140%
BBHC
102
Brown Brothers Harriman & Co
New York
$31K – – –
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$25K -$33.4K -6,773 -57%
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
$24.9K -$8.44K -1,713 -25%
Fidelity Investments
105
Fidelity Investments
Massachusetts
$12.6K -$11.8K -2,399 -49%
CUAMC
106
China Universal Asset Management Company
China
$6.84K +$1.7K +345 +33%
CAL
107
Capital Analysts LLC
Pennsylvania
$6K – – –
Osaic Holdings
108
Osaic Holdings
Arizona
$5.45K – – –
US Bancorp
109
US Bancorp
Minnesota
$3.28K +$3.26K +662 New
LC
110
Lindbrook Capital
California
$1.55K +$1.54K +313 New
Daiwa Securities Group
111
Daiwa Securities Group
Japan
$1K – – –
PC
112
Pier Capital
Connecticut
– -$5.86M -1,074,164 Closed
BCM
113
Bridgeway Capital Management
Texas
– -$553K -101,200 Closed
AR
114
Advisory Research
Illinois
– -$149K -27,204 Closed
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
– -$22K -4,468 -99%
Simplex Trading
116
Simplex Trading
Illinois
– -$5.01K -1,018 Closed
C
117
Covestor
United Kingdom
– -$34 -7 -30%
1 2 3 4
5

MXCT Hedge Fund Activity: Q1 2023 in Review

114 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q1 2023, worth a combined $489M — up 30% from $376M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new MXCT positions and 5 closed out — a net gain of 11 holders — while 51 added to existing stakes and 28 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $12M. The largest seller was Casdin Capital, cutting an estimated $22.6M.

  • 114 institutional investors held MaxCyte (MXCT) as of Q1 2023, up from 104 in Q4 2022.
  • Funds reported $489M of MaxCyte stock for Q1 2023, up 30% quarter-over-quarter.
  • 16 funds opened new MaxCyte positions in Q1 2023 and 5 closed out, a net change of +11 holders.
  • The largest MaxCyte buyer in Q1 2023 was Stonepine Capital Management, an estimated $12M added.
  • The largest MaxCyte seller in Q1 2023 was Casdin Capital, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2023.